Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Medicinal Chemistry|April 1, 1978
Antitubercular 2,8-bis(alkylaminomethyl)phenazinesK C Murdock, Y Lin, J P Thomas, et al.Cancer Research|May 1, 1979
Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in miceR E Wallace, K C Murdock, R B Angier, et al.Annals of the New York Academy of Sciences|January 1, 1985
Design of anticancer drugs using modeling techniquesV N Balaji, J S Dixon, D H Smith, et al.Journal of Medicinal Chemistry|July 23, 1993
N-phosphoryl derivatives of bisantrene. Antitumor prodrugs with enhanced solubility and reduced potential for toxicityK C Murdock, V J Lee, R V Citarella, et al.Cancer Research|February 1, 1982
Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in miceR V Citarella, R E Wallace, K C Murdock, et al.Journal of Medicinal Chemistry|March 1, 1978
Bisamidines of 2,6-diaminoanthraquinone as antiamebic agentsP F Fabio, T L Fields, Y Lin, et al.International Journal of Immunopharmacology|January 1, 1987
Relationship of chemical structures of anthraquinones with their effects on the suppression of immune responsesB S Wang, K C Murdock, A L Lumanglas, et al.Experientia|January 15, 1979
The effect of bisamidines of 2,6-diaminoanthraquinone on Entamoeba histolytica infections in rats and hamstersE J Burden, S G Carvajal, P F Fabio, et al.Journal of Medicinal Chemistry|September 1, 1979
Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenedionesK C Murdock, R G Child, P F Fabio, et al.Cancer Research|September 1, 1986
Identification of human urinary mitoxantrone metabolitesF S Chiccarelli, J A Morrison, D B Cosulich, et al.Pageof 2